Incentives and reminders to help people take HIV medicines regularly
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
This project uses daily reminders and small rewards to help people living with HIV keep a regular antiretroviral pill-taking routine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-11378660 on NIH RePORTER |
What this research studies
You’ll pick an existing daily habit (an "anchor") to pair with taking your HIV pills so taking them becomes automatic. Some participants will get daily reminder messages for three months to help stick to their plan, and others will get the same messages plus small monthly prizes when they take pills around their anchor. The team developed this approach after a successful pilot and will follow participants over time to see if routines and medication adherence improve. The goal is to make pill-taking easier and more automatic so it requires less effort.
Who could benefit from this research
Good fit: Ideal candidates are adults living with HIV who are prescribed daily antiretroviral therapy and want help building a pill-taking routine.
Not a fit: People who already take ART reliably every day or who cannot receive mobile messages or accept small incentives may be unlikely to benefit from this approach.
Why it matters
Potential benefit: If successful, this approach could help more people with HIV keep viral suppression by making daily ART adherence easier.
How similar studies have performed: A prior R34 pilot by the same team showed this anchoring-plus-behavioral-economics approach could establish pill-taking routines, but larger trials are still needed.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Linnemayr, Sebastian — Rand Corporation
- Study coordinator: Linnemayr, Sebastian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.